妊娠期急性脂肪肝患者的主要临床检验指标分析

doi:10.3877/cma.j.issn.2095-3232.2013.06.009

中华肝脏外科手术学电子杂志 ›› 2013, Vol. 02 ›› Issue (06) : 383 -385. doi: 10.3877/cma.j.issn.2095-3232.2013.06.009

所属专题：文献；

临床研究

妊娠期急性脂肪肝患者的主要临床检验指标分析

魏绪霞¹, 易小猛¹, 吕海金¹, 熊亮¹, 刘剑戎¹, 李敏如¹, 安玉玲¹, 危敏¹, 易慧敏¹^,^†(

)

^1. 510630　广州，中山大学附属第三医院外科重症监护病房

收稿日期:2013-08-19 出版日期:2013-12-10
通信作者: 易慧敏
基金资助:
广州市科技计划项目(2011Y1-0033-1)

Analysis on the major clinical indicators in patients with acute fatty liver of pregnancy

Xu-xia WEI¹, Xiao-meng YI¹, Hai-jin LYU¹, Liang XIONG¹, Jian-rong LIU¹, Min-ru LI¹, Yu-ling AN¹, Min WEI¹, Hui-min YI¹^,^†()

^1. Surgi-cal Intensive Care Unit, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

Received:2013-08-19 Published:2013-12-10
Corresponding author: Hui-min YI
About author:
Corresponding author: YI Hui-min, Email: ylhmin@hotmail.com

全文 ( ) 下载PDF ( ) 导出引用

目的

探讨妊娠期急性脂肪肝患者的主要临床检验指标变化特点。

方法

回顾性研究2009年3月至2013年8月在中山大学附属第三医院接受诊治的26例妊娠期急性脂肪肝患者临床资料。根据患者临床结局分为好转组与未好转组。好转组20例，年龄18~30岁，中位年龄25岁；未好转组6例，年龄20~29岁，中位年龄24岁。所有患者均签署知情同意书，符合医学伦理学规定。观察两组患者转入重症监护病房（ICU）24 h外周静脉血总胆红素（TB）、凝血酶原活动度（PTA）、血清肌酐（Scr）、空腹血糖（FPG）和动脉血乳酸（Lac）等主要临床检验指标的差异。两组患者主要临床检验指标的比较采用t检验。

结果

好转组转入ICU 24 h TB、PTA、Scr、FPG、Lac分别为（193±99）μmol/L、（48±17）%、（114±84）μmol/L、（5.7±2.9）mmol/L、（2.8±1.0）mmol/L，未好转组分别为（259±119）μmol/L、（37±14）%、（161±79）μmol/L、（4.7±2.6）mmol/L、（3.9±1.5）mmol/L，两组患者相应指标比较差异有统计学意义（t=-8.178，8.231，-11.913，7.541，-10.032；P<0.05）。

结论

妊娠期急性脂肪肝患者TB、PTA、Scr、FPG、Lac等主要临床检验指标异常，预后差者其异常更为明显。

关键词: 妊娠, 脂肪肝, 胆红素, 凝血酶原, 肌酸酐, 血糖, 乳酸

Objective

To investigate the characteristics of major clinical indicators changes in patients with acute fatty liver of pregnancy.

Methods

Clinical data of 26 patients with acute fatty liver of pregnancy from March 2009 to August 2013 in the Third Affiliated Hospital of Sun Yat-sen University were analyzed retrospectively. According to the clinical outcome, patients were divided into improvement group (n=20, 18-30 years old, median age of 25 years old) and no-improvement group (n=6, 20-29 years old, median age of 24 years old). The informed consents of all patients were obtained and the ethical committee approval was received. The differences of major clinical indicators such as total bilirubin (TB), prothrombin time activity (PTA), serum creatinine (Scr), fasting blood glucose (FPG) of peripheral venous blood and arterial lactic acid (Lac) in patients of two groups were observed at 24 h after transferred into the intensive care unit (ICU). The major clinical indicators in patients of two groups were compared by t test.

Results

The TB, PTA, Scr, FPG, Lac were (193±99)μmol/L, (48±17)%, (114±84)μmol/L, (5.7±2.9)mmol/L, (2.8±1.0)mmol/L respectively in improvement group 24 h after transferred into ICU, and were (259±119) μmol/L,(37±14)%, (161±79)μmol/L, (4.7±2.6)mmol/L, (3.9±1.5)mmol/L respectively in no-improvement group, where significant differences were observed in the corresponding indexes between two groups(t=-8.178, 8.231,-11.913, 7.541,-10.032; P<0.05).

Conclusions

The major clinical indicators such as TB, PTA, Scr, FPG, Lac in patients with acute fatty liver of pregnancy are abnormal. It is even obvious in patients with poor prognosis.

Key words: Pregnancy, Fatty liver, Bilirubin, Prothrombin, Creatinine, Blood glucose, Lactic acid

表1 两组患者转入重症监护病房24 h临床检验指标比较（±s）

组别	例数	WBC(×10⁹/L)	PLT(×10⁹/L)	ALB(g/L)	ALT(U/L)	TB(μmol/L)	PTA(%)	Scr (μmol/L)	FPG(mmol/L)	Lac(mmol/L)
好转组	20	13±3	167±67	27±6	131±72	193±99	48±17	114±84	5.7±2.9	2.8±1.0
未好转组	6	15±4	159±51	26±5	129±65	259±119	37±14	161±79	4.7±2.6	3.9±1.5
t值	?	-0.511	1.378	1.002	0.490	-8.178	8.231	-11.913	7.541	-10.032
P值	?	>0.05	>0.05	>0.05	>0.05	<0.05	<0.05	<0.05	<0.05	<0.05

表1 两组患者转入重症监护病房24 h临床检验指标比较（±s）

组别	例数	WBC(×10⁹/L)	PLT(×10⁹/L)	ALB(g/L)	ALT(U/L)	TB(μmol/L)	PTA(%)	Scr (μmol/L)	FPG(mmol/L)	Lac(mmol/L)
好转组	20	13±3	167±67	27±6	131±72	193±99	48±17	114±84	5.7±2.9	2.8±1.0
未好转组	6	15±4	159±51	26±5	129±65	259±119	37±14	161±79	4.7±2.6	3.9±1.5
t值	?	-0.511	1.378	1.002	0.490	-8.178	8.231	-11.913	7.541	-10.032
P值	?	>0.05	>0.05	>0.05	>0.05	<0.05	<0.05	<0.05	<0.05	<0.05

[1]	蒋佩茹,邱申熊.妊娠期肝病2137例临床分析.肝脏, 2006, 11(4): 247-248.
[2]	刘双莲,刘丽华.急性妊娠脂肪肝的临床分析.华西医学, 2010, 25(2): 384-385.
[3]	Ch′ng CL,Morgan M,Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut, 2002, 51(6): 876-880.
[4]	Brooks RR,Feller CM,Maye JP. Acute fatty liver of pregnancy: a case report. AANA J, 2002, 70(3): 215-217.
[5]	Guntupalli SR,Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med, 2005, 33(10 Suppl): S332-S339.
[6]	Lamireau D,Feghali H,Redonnet-Vernhet I, et al. Acute fatty liver in pregnancy: revealing fetal fatty acid oxidation disorders.Arch Pediatr（法文）, 2012, 19(3): 277-281.
[7]	Tein I. Metabolic disease in the fetus predisposes to maternal hepatic complications of pregnancy. Pediatr Res, 2000, 47(1): 6-8.
[8]	Bellig LL. Maternal acute fatty liver of pregnancy and the associated risk for long-chain 3-hydroxyacyl-coenzyme a dehydrogenase(LCHAD) deficiency in infants. Adv Neonatal Care, 2004, 4(1): 26-32.
[9]	曹泽毅.中华妇产科学. 2版.北京:人民卫生出版社, 2005：652-655.
[10]	张丽志,刘清华.妊娠期急性脂肪肝9例临床分析.实用妇产科杂志, 2006, 22(9): 546-548.
[11]	徐道振.病毒性肝炎临床实践.北京:人民卫生出版社, 2006: 239-314.
[12]	Yuen MF,Sablon E,Hui CK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis, 2003, 36(8): 979-984.
[13]	Zhang XQ,Jiang L,You JP, et al. Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure. Hepatol Res, 2011, 41(1): 46-53.
[14]	Franchini M,Franchi M,Bergamini V, et al. A critical review on the use of recombinant factor Ⅶa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost, 2008, 34(1): 104-112.
[15]	Bomken C,Mathai S,Biss T, et al. Recombinant activated factor Ⅶ (rFⅦa) in the management of major obstetric haemorrhage: a case series and a proposed guideline for use. Obstet Gynecol Int, 2009: 364843.
[16]	Lee SW,Hong YS,Park DW, et al. Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J, 2008, 25(10): 659-665.
[17]	Cusack RJ,Rhodes A,Lochhead P, et al. The strong ion gap does not have prognostic value in critically ill patients in a mixed medical/sugical adult ICU. Intensive Care Med, 2002, 28(7): 864-869.
[18]	晋茂生.妊娠期急性脂肪肝.中华全科医学, 2008, 6(10): 1098-1099.

[1]	杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[2]	陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[3]	居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[4]	顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[5]	王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[6]	陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[7]	周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[8]	钟文文, 李科, 刘碧好, 蔡炳, 脱颖, 叶雷, 马波, 瞿虎, 汪中扬, 王德娟, 邱剑光. 不同比例聚乳酸/丝素蛋白复合支架在兔尿道缺损修复中的疗效[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 516-522.
[9]	杨聚荣. 透析患者妊娠的管理[J]. 中华肾病研究电子杂志, 2023, 12(05): 300-300.
[10]	黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[11]	张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[12]	孙旻. 血液淀粉酶、C反应蛋白、降钙素原及乳酸脱氢酶在急性胰腺炎患者病情评价及预后预测中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 331-336.
[13]	李运林, 娄冬华. 滨海县非酒精性脂肪肝发病与消退的影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 354-358.
[14]	薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
[15]	孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Analysis on the major clinical indicators in patients with acute fatty liver of pregnancy

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Analysis on the major clinical indicators in patients with acute fatty liver of pregnancy